Skip to main navigation Skip to search Skip to main content

American Society for Pain Management Nursing Guidelines on Monitoring for Opioid-Induced Advancing Sedation and Respiratory Depression: Revisions

  • Carla R. Jungquist
  • , Ann Quinlan-Colwell
  • , April Vallerand
  • , Heather L. Carlisle
  • , Maureen Cooney
  • , Susan J. Dempsey
  • , Danielle Dunwoody
  • , Angelika Maly
  • , Kathy Meloche
  • , Ashley Meyers
  • , Jason Sawyer
  • , Navdeep Singh
  • , Denise Sullivan
  • , Chris Watson
  • , Rosemary C. Polomano
  • Private Practice Pain Management Consulting and Education
  • Wayne State University
  • University of Arizona
  • Westchester Medical Center
  • University of California at Los Angeles
  • Halton Healthcare
  • Harper University Hospital
  • Sparrow Health System
  • University of Toronto
  • NYC Health + Hospitals/Jacobi
  • East Alabama Medical Center
  • University of Pennsylvania

Research output: Contribution to journal › Article › peer-review

59 Scopus citations

Abstract

Objectives: This report presents up-to-date evidence and expert consensus-based revisions to the ASPMN 2011 guidelines that inform interprofessional clinical decision-making for hospitalized adults receiving opioid analgesics. Design: Systematic review of the literature. Methods: A 14-member expert panel was charged with reviewing and grading the strength of scientific evidence published in peer reviewed journals and revising the ASPMN 2011 existing guidelines. Panel members formulated recommendations based on the strength of evidence and reached consensus through discussion, reappraisal of evidence, and voting by majority when necessary. The American Society of Anesthesiologists evidence categories for grading and classifying the strength of the evidence were used. Recommendations were subjected to a critical review by ASPMN members as well as external reviews. Results: The 2011 guidelines were found to still be relevant to clinical practice, but new evidence substantiated refinement and more specific recommendations for electronic monitoring. The revised guidelines present risk factors divided into three categories: patient-specific, treatment-related, and environment of care. Specific recommendations for the use of electronic monitoring are delineated. Conclusions: All hospitalized patients that are administered opioids for acute pain are at risk of opioid induced advancing sedation and respiratory depression, but some patients are at high risk and require extra vigilance to prevent adverse events. All patients must be assessed for level of risk. Adaptations to the plan of care and monitoring strategies should be driven by iterative re-assessments according to level of risk. Nursing Practice Implications: Opioid medications continue to be a major component in the management of acute pain. Clinicians have the primary responsibility for safe and effective pain management. Evidence based monitoring strategies can improve patient safety with opioids.

Original languageEnglish
Pages (from-to)7-25
Number of pages19
JournalPain Management Nursing
Volume21
Issue number1
DOIs
StatePublished - Feb 2020

Fingerprint

Dive into the research topics of 'American Society for Pain Management Nursing Guidelines on Monitoring for Opioid-Induced Advancing Sedation and Respiratory Depression: Revisions'. Together they form a unique fingerprint.

Cite this